Navigation Links
Ingredient in turmeric protects skin

A compound found in turmeric can protect the skin from burns and blisters that are a hazard of radiotherapy. Curcumin is the substance that gives turmeric, //an ingredient of curries, its distinctive yellow colour. It is long been known for its health benefits, and recent research suggests it may fight cancer by cutting off the blood supply to a tumour.

Now researchers at the University of Texas uncover that curcumin has another potential benefit. Working with mice, they have found that curcumin can protect the skin from the damaging blisters and burns that develop radiotherapy. A group of mice were given various doses of the compound and then exposed to a dose of radiation. Those given the higher doses had far fewer burns or blisters. They also developed new cells in the area of tumour, which might be expected to make the therapy more effective. It is too early to know if this would work in humans, but curcumin could turn out to be a safe and natural way of protecting the skin from radiotherapy.


'"/>




Page: 1

Related medicine news :

1. Cough Syrup Ingredient Linked to Stroke
2. Soluble Ingredient Can Make Fatty Fast Foods Healthier
3. Red Cross Says Fund Boost and Awareness Are the Main Ingredients to Fight AIDS
4. Shampoo Ingredient Interferes With Memory In Mice
5. GGC - A New Ingredient To Fight Ageing
6. Combined Ingredients may Cut Cholesterol Levels
7. Common Ingredient in Big Macs and Sodas Can Stabilize Gold Nanoparticles for Medical Use
8. Curry Powder (haldi or turmeric) can prevent cancer
9. The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties
10. Beer vitamin protects heart
11. B Vitamin protects and lowers toxicity of Arthritis Drug
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ingredient turmeric protects skin

(Date:10/10/2008)...ILLE, PA The American Nurses Credentialing Center...MC) as a Magnet hospital. The news came via a conf... staff who broke out with cheers and applause., G...spitals and only 294 hospitals in the United Stat...00 hospitals are eligible for this recognition., ...
(Date:10/10/2008)...suggests poor self-care partly to blame , ... of Medicare beneficiaries who have diabetes, bein...e, according to a new study. , Publishing in ...nal Medicine , researchers from the University of ...average age of 75.6 years) who had diabetes and we...
(Date:10/10/2008)... Honoring excellence in the imp...he Healthcare Information and Management Systems S...8 Davies Awards in the Organizational, Ambulatory ... Chicago, IL (PRWEB) October...tion of electronic health records (EHRs), the Hea...
(Date:10/10/2008)...W YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins ... multimedia educational program,"Optimizing Adjuv...reatment,Selection," to present recent key researc...atment., In recent years, advancements in the tre...ic and biologic treatment combinations that are,in...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... Staphylococcus Aureus) is a bacteria resistant to...tly in patients who suffer //from weakened immune ... and is known to spread because of poor hygiene. C..., and Norway, where MRSA has been relatively low a...
...– 'In Zambia, people in the tourist resort city of... after finding dead chickens at the owners backyar...e health ministry, said 'No confirmed evidences we...gation of the outbreak'. The number of chickens, ...
...shed in the near future for those suffering with t... Health Minister Mary Harney said that he would s... Bill to address insurance difficulties faced by p...ses while administering blood and blood products. ...
...cted by Yale university researchers it was found t...life resulted in an increased rate of heart attack... age group of 51 to 61 years. The results of the s...onmental Medicine journal. Out of which 582 people...
Other Medicine News:Health News:Super-bug MRSA Getting Fitter And Out of Control 2
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmeti.../- MatTek Corp. today announced,that ...lti-laboratory,"catch-up" validation study on MatT.... The test results demonstrated the required sensi...as a validated alternative to animal,testing for d...
(Date:10/8/2008)... Cornell University Food Scientists Expand ...xidant Activity Assay, PORTLAND, Maine, Oct. 8 /P...advanced today with the release of results from a ...dozen other commonly consumed,fruits like apples, ...d,test using the Cellular Antioxidant Activity (CA...
(Date:10/8/2008)... -- Exploratory study shows clinical improvem...tension (PAH), -- Current treatment options hav...dly progressive and incurable blood vessel disease... for treatment of certain cancers, known to i... to further explore potential of imatinib mesylate...
(Date:10/7/2008)... AUSTIN, Texas, Oct. 7 /- The Te...id,s Medical Center has been selected as one of,on...FDA-approved clinical,trial for a new device to tr...national treatment, training and research center s...rship between St. David,s Medical Center and,Texas...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 1Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 2Hospital for Special Surgery Ranked No 1 by U S News 26 World Report 23781 3M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 3995 1M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 3995 21 3 of reef building corals face extinction 3994 11 3 of reef building corals face extinction 3994 21 3 of reef building corals face extinction 3994 31 3 of reef building corals face extinction 3994 4NCOA Applauds Senate Passage of Medicare Bill 23773 1NCOA Applauds Senate Passage of Medicare Bill 23773 2
..., June 07, 2007 /PRNewswire-FirstCall/ -,Neurochem...ed,subsidiary of Neurochem Inc. , announces that t...d the results of the "Eprodisate,For AA Amyloidosi...l trial in the search for a treatment of AA amyloi...ial for eprodisate,(KIACTA(TM)) demonstrate that t...
...ting zonisamide SR as a novel component in,EMPATIC...2007 /PRNewswire-FirstCall/ -- Orexigen(TM),Therap... on the,treatment of central nervous system disord...ced results from a Phase I trial evaluating,safety...ustained-release (SR) formulation of zonisamide. I...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.
Certified by an independent laboratory to meet Class 100 specifications of Federal Standard 209E. Ergonomic seat guarantees worker confort, reduces fatique and back injuries. Clean vinyl meets Class
Inquire
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in.
Medicine Products: